Media coverage
3
Media coverage
Title Belgium : New TREMFYA (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis Media name/outlet Tendernews.com Country/Territory India Date 3/11/22 URL ct.moreover.com/?a=49165240655&p=1gw&v=1&x=tkXRYOW9tyciuqsgQv0mbQ Persons Bruce E. Sands Title Belgium : New TREMFYA (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis Media name/outlet TendersInfo – News Country/Territory India Date 27/10/22 URL ct.moreover.com/?a=49108708669&p=1gw&v=1&x=GzAGqYpOSt-qxpRJXUfxxw Persons Bruce E. Sands Title Belgium : New TREMFYA (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis Media name/outlet Mena Report Country/Territory United Kingdom Date 27/10/22 URL ct.moreover.com/?a=49105496535&p=1gw&v=1&x=4n3wsP2c8e9VOASS7ZKBAw Persons Bruce E. Sands